The role of indoleamine-2,3-dioxygenase in development of antitumor immune response tiggered by photodynamic therapy
2014/13/D/NZ6/01080
Keywords
Descriptors
- NZ6_8: Inne zagadnienia pokrewne
- NZ1_1: Biologia molekularna
- NZ5_9: Inne zagadnienia pokrewne
Panel
NZ6 – Human and animal immunology and infection: immunity, immune disorders, immunotherapy, infectious and invasive diseases, microbiology, transplantology, allergology
Host institution
Warszawski Uniwersytet Medyczny, I Wydział Lekarski
Voivodeship: mazowieckie
Principal investigator (from the host institution)
Number of co-investigators in the project: 2
Call
SONATA 7 – announced on 2014-03-17
- Amount awarded
- 691 987 PLN
- Project start date
- 2015-02-02
- Project end date
- 2018-08-01
- Project duration
- 42 months (the same as in the proposal)
- Project status
- Project settled
Information in the final report
Publication in academic press/journals (2)
-
Inhibition of lymphangiogenesis impairs antitumour effects of photodynamic therapy and checkpoint inhibitors in mice
- Authors:
- Angelika Muchowicz, Malgorzata Wachowska, Joanna Stachura, Katarzyna Tonecka, Magdalena Gabrysiak, Dominika Wołosz, Zofia Pilch, Witold W. Kilarski, Louis Boon, Tomasz J. Klaus, Jakub Golab
- Academic press:
- European Journal of Cancer (year: 2017, volume: 2017 Sep;83:, pages: 19-27), Publisher: Elsevier
- Status:
- Published
- DOI:
- 10.1016/j.ejca.2017.06.004. – link to the publication
-
Inhibition of IDO leads to IL-6-dependent systemic inflammation in mice when combined with photodynamic therapy
- Authors:
- Malgorzata Wachowska, Joanna Stachura, Katarzyna Tonecka, Klaudyna Fidyt, Agata Braniewska, Zuzanna Sas, Iwona Kotula, Tomasz P Rygiel, Louis Boon, Jakub Golab, Angelika Muchowicz
- Status:
- Accepted for publication